Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
AIDS Healthcare Foundation
AHF Praises Merck for AIDS Drug Price Freeze in US
August 22nd, 2008
AIDS Healthcare Foundation (AHF) the US-based NGO which provides HIV/AIDS medical care and/or services to more than 79,000 individuals in 20 countries worldwide--including at four free treatment clinics in Mexico--lauded Merck & Company over it intention to freeze the price on its second-line antiretroviral AIDS drug therapy Isentress (raltegravir) for US government programs such as the federally funded, state-run AIDS Drug Assistance Programs (ADAP). Merck, which announced its intentions in a press statement last week, will freeze the price of Isentress at its 2007 launch price. "Merck's decision to freeze the price of Isentress at its 2007 launch price for government...
Source: Health Business Week (2008-08-22)
|
